Status:
COMPLETED
Sing for Your Saunter - Dementia Supplement
Lead Sponsor:
Washington University School of Medicine
Conditions:
Parkinson Disease
Parkinson Disease Dementia
Eligibility:
All Genders
30+ years
Phase:
NA
Brief Summary
Older adults, and particularly those with Parkinson disease (PD), may experience walking difficulties that negatively impact their daily function and quality of life. People that have PD plus dementia...
Detailed Description
During this observational study, participants will attend one visit in the laboratory. The visit will include participants wearing wearable sensors during the following tasks: walking with no cues (UN...
Eligibility Criteria
Inclusion
- at least 30 years of age
- diagnosis of idiopathic, typical Parkinson disease according to the UK Brain Bank Criteria
- Hoehn \& Yahr stages 2-3 (mild to moderate disease severity)
- normal or corrected hearing
- stable on all PD medications for at least 2 months prior to study entry
- dementia as defined by a Clinical Dementia Rating (CDR) score of 0.5-1.0 (very mild to mild dementia)
- score of ≥ 1 on the MDS-UPDRS-III Item #10 indicating observable gait impairment
- a score of 1 or less on item #7 on the freezing of gait questionnaire
- able to walk for 10 continuous minutes independently
Exclusion
- diagnosis of any other neurological condition
- unstable medical or concomitant illnesses or psychiatric conditions which, in the opinion of the investigators, would preclude successful participation
- cardiac problems that interfere with ability to safely participate (i.e., uncontrolled congestive heart failure, myocardial infarction in past 6 months, complex cardiac arrhythmias, significant left ventricular dysfunction, dyspnea on exertion, chest pain or pressure, resting tachycardia (\>100 beats/min); uncontrolled BP (resting systolic BP \>160 mmHg or diastolic BP \>100 mmHg))
- orthopedic problems in the lower extremities or spine that may limit walking (i.e., severe arthritis, spinal stenosis)
- uncontrolled tremor or dyskinesia while on PD medications
Key Trial Info
Start Date :
April 19 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 15 2023
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04518917
Start Date
April 19 2021
End Date
May 15 2023
Last Update
January 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine Program in Physical Therapy
St Louis, Missouri, United States, 63110